Comparison Quality of Life and Emotional Processing among Patients with Major Thalassemia, Type 2 Diabetes Mellitus, and Healthy People

AUTHORS

Fatemeh Pourmohammad Fahreh 1 , Mahmoud Shirazi 2 , *

1 University of Sistan and Baluchestan, Zahedan, Iran

2 Department of Psychology, University of Sistan and Baluchestan, Zahedan, Iran

How to Cite: Pourmohammad Fahreh F, Shirazi M. Comparison Quality of Life and Emotional Processing among Patients with Major Thalassemia, Type 2 Diabetes Mellitus, and Healthy People, Jundishapur J Chronic Dis Care. Online ahead of Print ; In Press(In Press):e94799. doi: 10.5812/jjcdc.94799.

ARTICLE INFORMATION

Jundishapur Journal of Chronic Disease Care: In Press (In Press); e94799
Published Online: June 6, 2020
Article Type: Research Article
Received: November 11, 2019
Revised: April 26, 2020
Accepted: May 3, 2020
Uncorrected Proof scheduled for 9 (2)
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Objectives: This study aimed at comparing emotional processing and quality of life among patients with major thalassemia, type 2 diabetes mellitus, and healthy individuals.

Methods: The present causal-comparative study was conducted on patients with thalassemia, type 2 diabetes mellitus, and healthy people in Saravan City in 2017. In this study, the available sampling method was conducted and 153 individuals (major thalassemia = 53, type 2 diabetes mellitus = 50, and healthy people = 50) were selected. Later, emotional processing and quality of life questionnaires were distributed among the participants. The data were analyzed using multivariate analysis of variance and Tukey post hoc test by running SPSS version 23.

Results: In the thalassemia group, the mean score of emotional processing was higher than the other two groups; whereas, the mean score of the quality of life was lower compared with the other study groups. The three groups were significantly different in terms of emotional processing and the quality of life. The paired comparison between the groups showed that the signs of unprocessed emotion components of emotional processing were lower in the healthy group compared with the two patients’ groups. However, among the components of the quality of life, the mean scores of personal benefit, relationships, and environmental factors were higher among the healthy group.

Conclusions: Chronic diseases affect emotional processing and the individuals’ quality of life. Therefore, we recommend to health centers to conduct comprehensive and preventive programs to improve participants’ mental health.

Copyright © 2020, Jundishapur Journal of Chronic Disease Care. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

Today, it is believed that major health problems are related to chronic diseases (1). Chronic diseases affect the routine and daily activities of life (2). On the one hand, physiological factors, as well as psychological causes, play a role in the incidence of chronic diseases (3). Furthermore, determining the psychological problems of patients with chronic diseases and trying to solve them are of great importance since they impose high costs on the individual and society (4, 5). Psychological problems of such patients include emotional processing and regulation, as well as the quality of life.

Through emotional processing, emotional or psychological disturbances are absorbed and reduced to the degree that individuals can continue their other experiences and behaviors without any difficulties (6). Four categories of factors may also cause problems in emotional processing: cognitive avoidance (the process in which the mind refuses to accept the events), lack of experience in short-term habit formations, depression, and overvalued ideas (7). The results of previous studies show that people who use weaker cognitive styles, such as rumination, catastrophic thinking, and self-blame, are more vulnerable to emotional problems. However, individuals who use preferred styles, such as positive re-evaluations are less vulnerable (8).

Mund and Mitte (9) indicated that people who suppressed their excitement had a higher risk of developing certain diseases. The disturbing emotions create a bias of attention and cause a disturbance in emotional processing. Research findings show that those who choose ineffective styles during emotional processing are more vulnerable to emotional problems (10-12). Patients with chronic stress and negative excitement, such as fear and anger are very sensitive and have a problem in controlling their stress and regulating their emotions (13). In some psychological trauma, one or more components of emotional processing are disturbed. These disturbances occur in the incidence of emotions. Consequently, the ability of patients to perform one or more adaptive emotional functions is impaired (7).

Emotional processing, one of the most important effective variables in quality of life and mental health, is defined as positive or negative strategies applied by individuals to deal with adverse and stressful life events (14). Based on pieces of evidence, negative strategies inversely correlate with depression, but positive strategies have a significant negative correlation with mental health indicators and quality of life. In other words, individuals’ mental health and quality of life depend on the interaction between the application of certain types of emotional processing strategies and appropriate assessment of stressful situations (15).

The quality of life has been investigated as an important issue in health care research, especially in chronic disease studies. The literature shows that the diagnosis of chronic diseases directly affects the patients’ quality of life and changes their daily lives in different ways (16). Chronic diseases have a negative impact on the patients’ quality of life as a multifactorial issue (17). One of the influential factors on individuals’ quality of life is emotional processing that is a basic concept in psychology (18).

The quality of life, which is defined as the characteristics that people require to maintain their abilities to conduct valuable life activities and chronic diseases, has negative effects on the health and quality of life (19). Today, the quality of life is considered an important issue and consequence of health in treating and taking care of chronic patients (20). The health-related assessment of the quality of life is important for physicians and health policymakers (21). Studies showed that patients with thalassemia had lower quality of life than the control group (22, 23). In this regard, patients with diabetes mellitus had significantly lower levels of mental health and quality of life than the control group (2, 24, 25). Camacho et al. (26) studied the quality of life among patients with diabetes mellitus and concluded that increased severity of diabetes had a significant negative effect on the patients’ quality of life, especially in terms of psychosocial aspects. Similar studies also mentioned that other chronic diseases, such as diabetes mellitus, affect various dimensions of people’s lives and reduce their quality of life (27). As a result, chronic diseases that require hard work for treatment reduce the individuals’ quality of life (1). Over the past two decades, the results of studies showed that the main goal of treatment was not only to eliminate the disease symptoms and signs but also to improve the overall patients’ quality of life. In order to achieve this goal, the psychological and psychosocial consequences of diseases should be taken into consideration (28).

2. Objectives

Considering the results of other similar studies, and the importance of psychological problems in chronic patients, psychological problems, along with physical injuries of these patients should be noted. As a result, the lack of research in this field led the researchers of this study to compare emotional processing and quality of life among patients with thalassemia major and type 2 diabetes mellitus and healthy people. The aim of this study was to provide useful information about these diseases and the current needs in this field to take effective measures in improving patients’ mental and physical health.

3. Methods

This causal-comparative study was conducted on all patients with thalassemia and type 2 diabetes mellitus and healthy people who referred to health care centers of Saravan City for examination and treatment in 2017 - 2018. Considering the limited number of the statistical population in this research, the available sampling method was used, and all people who referred to the health centers (n = 153) were selected by the Morgan sampling table. The participants included 53 patients with thalassemia major, 50 patients with type 2 diabetes mellitus, and 50 healthy individuals, who were matched in terms of age and gender. The study was carried out within a six-month period. The inclusion criteria were passing at least one year from the onset of chronic disease, diagnosing the disease by the physician, having the age of 16 and over, having the reading and writing skills, having no psychiatric and cognitive problems, having consent to participate in the study, and having no chronic diseases for the healthy people. The participants were explained about the study objectives, were asked to carefully read the questions and select the responses according to their characteristics, and were also required to answer all the questions. The questionnaires were completed individually. Patients with acute conditions and those who could not complete the questionnaire were not included in the research. The exclusion criteria were reception of psychiatric treatment, reluctance to participate in the study, and incomplete questionnaires.

Data collection tools consisted of two questionnaires:

1) Emotional Processing Questionnaire: This scale, developed by Baker et al. (8) in 2010, has 25 items and aims at evaluating the components of emotional processing (suppression, uncontrollable emotions, emotional experiences, signs of unprocessed emotions, and avoidance). The questionnaire items should be scored based on a five-point Likert scale (totally disagree = 1, disagree = 2, no idea = 3, agree = 4, totally agree = 5). The minimum and maximum attainable scores are 25 and 125, respectively. Scores of 25 - 50 represent poor emotional processing, 50 - 75 show moderate emotional processing, and 75 - 125 indicate very high emotional processing. With regard to this questionnaire, Cronbach’s alpha coefficient was 0.92, and its test re-test reliability coefficient was calculated as 0.79 (8). Cronbach’s alpha coefficient of this scale was reported as 0.95 in the previous research (Lotfi et al., 2012) (29). Cronbach’s alpha coefficient was calculated as 0.73 in the present study.

2) Quality of Life Questionnaire: It was designed by Michael Friesch in 1992 to measure each individual’s quality of life. The questionnaire is a self-report scale, assesses the importance that individuals give to every 16 domains of life quality, and shows their recent satisfaction in each area. This tool is completed very quickly and is useful for evaluating the outcomes of the treatment and mental therapy plans. The four sub-scales of self (health, self-esteem, goals and values, and living standards), personal gain (job, entertainment, learning, creativity, service), relationships (love, friendships, relationships of children, relationship with relatives), and environmental factors (home, neighborhood, community) are scored on a three-point Likert scale (0 = not at all important, 1 = important, 2 = very important). Regarding each area, the importance score is multiplied by the satisfaction score, and the satisfaction value is achieved. These scores are then summed and determine the individuals’ quality of life. Higher scores represent a higher quality of life. This questionnaire is standardized in the adult community and among the clinical and non-clinical groups. Based on three clinical and non-clinical samples, the validity of this scale was in the range of 0.87 - 0.91 and its internal reliability varied from 0.77 to 0.89 (30). In our study, the reliability of this questionnaire was calculated as 0.71 using Cronbach’s alpha.

3.1. Ethical Considerations

The participants were explained about the study purpose and received the required instructions about completing the questionnaires. Later, they were asked to sign the informed consent forms. In answering the questionnaires, the researcher provided the participants with the required clarifications in the case that they had any questions in understanding the items. It should be noted that these explanations were provided to avoid any kind of ambiguity or prejudice. In order to ensure the confidentiality of the data, a code was dedicated to each participant, and the information was interpreted based on these codes. The code of Ethics for the present study was 254047. This code is the code approved by the dissertation because it did not have the Ethics Committee at the time of the university’s dissertation approval.

3.2. Statistical Analysis

Data were analyzed by SPSS version 23 using descriptive statistics (mean, standard deviation) and inferential statistics, including MANOVA and Tukey post hoc test.

4. Results

Based on the demographic data of 153 participants (53 patients with thalassemia major, 50 patients with type 2 diabetes mellitus, and 50 healthy participants), the participants’ age ranged from 16 to 59 years. In the thalassemic group, 50.9% of the participants were women, while in the groups with type II diabetes and healthy groups, 54% and 58% of the individuals were male, respectively.

In Table 1, the mean and standard deviation of study variables are presented for all study groups, i.e., thalassemia, type 2 diabetes mellitus, and healthy.

Table 1. The means and (Standard Deviation) of Research Variables for Three Study Groupsa
VariableThalassemia (N = 53)Type 2 Diabetes (N = 50)Healthy (N = 50)
Emotional processing
Suppression16.15 ± 3.9814.52 ± 2.7312.96 ± 4.34
Uncontrollable emotions13.30 ± 3.9813.96 ± 2.1113.28 ± 2.79
Emotional experiences13/44 ± 3.5713.68 ± 2.4912.06 ± 4.60
Signs of unprocessed emotions15.00 ± 4.0315.50 ± 2.4013.36 ± 3.79
Avoidance17.49 ± 4.0716.82 ± 2.3516/78 ± 3.63
Total emotional processing score75.41 ± 11.2974.48 ± 7.3268.44 ± 14.49
Quality of life
Self36.20 ± 17.1633.74 ± 13.4037.56 ± 12.16
Personal gain94.37 ± 41.2885.86 ± 33.39121.40 ± 39.94
Relationships40.72 ± 17.5146.40 ± 19.4373.69 ± 25.29
Environmental factors34.35 ± 13.5128.94 ± 15.8540.28 ± 10.84
Total quality of life score189.26 ± 58.74238.64 ± 64.05245.64 ± 56.75

aValues are expressed as mean ± SD.

The results of Table 1 indicate that the mean of emotional processing and its subscales (suppression, uncontrollable emotions, emotional experiences, signs of unprocessed emotions, and avoidance) decreased in the healthy group compared to the groups with diabetes and thalassemia. However, the mean quality of life and its subscales (self, personal gains, relationships, and environmental factors) increased in the healthy group compared to the other two groups. In order to compare the effect of one independent variable on more than one dependent variable, multivariate analysis of variance (MANOVA) should be used. So, was used MANOVA to investigate differences among the three groups with regard to emotional processing and quality of life.

The type of group had a significant effect on the linear composition of emotional processing (Eta = 0.97, P = 0.002, P = 0.001, F = 2.93) and quality of life (Eta = 0.26, 0.05 = 0.05) P, 41/13 = F). In order to study the effect of group on emotional processing and quality of life, multivariate analysis of variance was carried out.

Table 2 shows the difference among groups with regard to emotional processing. The observed F value shows that only subscales of suppression and signs of unprocessed emotions, among emotional processing components were significantly different among the three groups. Tukey’s post hoc test was used to determine the difference between the groups. According to the results of the Tukey test, the mean score of suppression was significantly lower in the healthy individuals (12.96) than that of the thalassemia group (16.15) (P = 0.001 > 0.05). Furthermore, a significant difference was observed among the mean scores of the signs of unprocessed emotions for the healthy participants (13.36), patients with diabetes (15.00), and patients with thalassemia (15.00). The mean score of the healthy group was lower than the groups of patients with diabetes and thalassemia.

Table 3 represents the results of the multivariate analysis of variance among the groups. The observed rate of F-value for the subscales of the quality of life shows a significant difference among the three groups with regard to the subscales of personal gains, relationships, and environmental factors. Tukey’s post hoc test was run to determine the difference among groups. The results showed that the differences among the mean scores of healthy individuals (12.12) as well as patients with diabetes mellitus (85.86) and thalassemia (94.37) were significant with regard to the personal gain. Moreover, a significant difference was observed between the two groups with thalassemia and diabetes. Considering the subscale of relationships, the mean score of healthy people (73.69) was significantly different from those of patients with thalassemia (40.72) and diabetes (46.41). The mean score of environmental factors was higher in the healthy group (40.28) than the diabetic group (28.94).

5. Discussion

The purpose of this study was to evaluate emotional processing and quality of life among patients with major thalassemia, type 2 diabetes mellitus, and healthy individuals. The findings showed a significant difference between the three groups in terms of emotional processing and quality of life (Tables 2 and 3). The results of this study were confirmed partially by some previous studies (10-12, 25, 31-43).

Table 2. Results of Multivariate Analysis of Variance to Examine the Difference of Emotional Processing Among the Groups
SourceDependent VariableSum of SquaresdfMean of SquareFSigPartial Eta Squared
GroupsSuppression262.192131.099.280.0010.11
Uncontrollable emotions15.0627.530.790.4500.01
Emotional experiences78.15239.072.910.0570.03
Signs of the unprocessed emotions125.74262.875.140.0070.06
Avoidance16.5528.280.690.5000.01
Table 3. Results of the Multivariate Analysis of Variance Conducted to Examine Differences in the Quality of Life Among the Groups
SourceDependent VariableSum of SquaresdfMean of SquareFSigPartial Eta Squared
GroupsSelf375.572187.780.890.410.01
Personal gain34542.91217271.4536.230.0010.32
Relationships32270.75216135.3711.960.0010.13
Environmental factors3217.0821608.548.740.0010.10

The results of studies showed that patients with diabetes had poorer emotional regulation than the control group (31, 32). People who chose inappropriate styles during emotional processing were more vulnerable to emotional problems (10-12). People who suppress their emotions have a higher risk of developing certain diseases. As a result, the disease has the potential to bring about plenty of emotional complications. So, effective psychological interventions should be conducted to reduce distress and help cognition challenges. People who suppress emotions do not experience strong negative emotions. They exercise great control over their emotions and behaviors and avoid threatening information defensively (33). The stress responses of suppressive people are as large as or greater than those who welcome their distress (34, 35). These individuals are prone to physical illnesses in the long-term and experience more health problems (33). If emotions are regulated by suppression, they will cause harmful effects on health (36). People with chronic diseases recognize negative images more than those with positive images. Therefore, people with chronic diseases should be educated to increase their tolerance by neglecting negative stimuli and improve their emotional regulation significantly (33).

Compared with healthy individuals, patients with chronic diseases experience higher levels of emotional and mood problems, which can affect the disease course and prognosis. Emotional processing training is of great importance for patients with chronic diseases because it works specifically to regulate their excitement and mood (38). Emotional processing along with techniques and skills, such as mindfulness, endurance tolerance, and interpersonal communication, provide people with new solutions and help them to adjust the effects of distressing conditions caused by diseases such as diabetes mellitus, major thalassemia, and related excitements better (37).

To explain this finding, it can be mentioned that the relationship between emotions and health has a fundamental place in the field of psychology of health. In this regard, experiencing emotions and expressing them can play a vital role in a person’s health. Efforts to suppress negative emotions are one of the main components in the formation and development of a variety of physical illnesses. Suppressed negative emotions can lead to serious diseases. For this reason, emotion regulation and expression have an important role in adapting to chronic diseases and understanding emotions, which can help the patients’ mental health. Therefore, patients with chronic diseases can adapt to the problems and opportunities that they face in life using emotion processing. They can also inhibit or reduce the negative emotions by employing psychological skills to counteract negative emotions effectively. Psychological skills training can lead to better adaptation, higher life satisfaction, and better life quality.

The literature showed that patients’ quality of life with chronic diseases was lower than that of healthy people. In fact, physical impairments and symptoms had a direct effect on all aspects of the quality of life (39). Complications of chronic diseases, reduced life expectancy, and increased mortality rates impose a large burden on the individual, family, and society. They also affect the individuals’ and families’ quality of life (40). Lack of attention to individuals’ quality of life can lead to disappointment, lack of motivation, as well as reduction of economic, social, and health activities. In a deeper dimension, it can affect the socio-economic development of a country (41). Patients with thalassemia had low scores in all aspects of quality of life. Impaired quality of life in these patients had a negative impact on their social, family, work, and leisure activities and increased the risk of hospitalization and mortality caused by this disease (42).

Thus, it can be said that the chronic and tiring nature of chronic diseases affects the patients’ quality of life (25). In order to control such diseases appropriately, the patients’ quality of life should be improved, which also reduces health care costs (43).

The findings showed that patients with diabetes mellitus and major thalassemia had a lower quality of life than healthy people. So, determining psychological damages of such diseases provides healthcare professionals with more related information and helps them benefit from a more comprehensive approach in the treatment process. Consequently, the treatment process of these patients should not be limited to physiological approaches. In other words, considering the role of psychological variables in the treatments will improve their efficiency and facilitate further comprehensive steps in the treatment of mental disorders.

Consequently, people with chronic illnesses consider that these diseases are associated with the feeling of hopelessness and bad health status compared with other people, which leads to a decrease in their general health and quality of life. Low quality of life scores for these patients and the need for better adjustment of these patients to their illnesses require psychological counseling and psychosocial support services.

5.1. Conclusions

Chronic diseases such as major thalassemia and type 2 diabetes mellitus are considered the most important problems in today’s societies and decrease the patients’ quality of life and mental health of the community depending on their severity and frequency. Considering the findings of this research and other similar studies, a significant difference was observed among patients with major thalassemia, type 2 diabetes mellitus, and healthy individuals with regard to emotional processing and quality of life. Emotional processing had the highest mean score in the thalassemia group; whereas, the mean of thalassemia group in the quality of life was lower than the other groups. Therefore, consideration of the physiological approach is not enough in patients’ treatment process. In the case of considering the role of psychological variables in the etiology and treatment area, the therapeutic process and effects will be more efficient and long-term. Therefore, investigation of the effective psychological factors in the occurrence of these diseases is of great importance. For this reason, emotion regulation interventions provide this opportunity for chronic patients to reassess their life goals and priorities. By simultaneous implementation of the psychological therapies and medical treatments, an increasing number of chronic patients can improve and return to the community. With the cooperation of physicians and psychologists, more comprehensive measures should be taken to treat psychosomatic disorders. In this regard, comprehensive and preventive programs should be implemented by health centers to improve the individuals’ mental health.

5.2. Limitations

Some limitations of the present research included its cross-sectional design and patients’ lack of concentration due to the crowded environment of the hospital. Furthermore, specific types of thalassemia and diabetes were not studied; so, we recommend that researchers compare the quality of life and emotional processing in specific types of thalassemia and diabetes mellitus. Moreover, patients with other diseases should be investigated so that the comparison of the results can result in more comprehensive and accurate findings. Other researchers can also focus on these diseases’ aspects and psychological effects at all levels of treatment and hold regular training courses on positivism and emotion regulation for the staff working in special disease centers. The results of such pre- and post-intervention findings can enhance the generalizability and richness of the obtained information and provide more accurate explanations about the extent and type of relationship between these variables.

Acknowledgements

Footnotes

References

  • 1.

    Razzazan N, Ravanipour M, Jahanpour F, Zarei AR, Motamed N, Hosseini S. Investigating challenges facing self-management empowerment education in adolescents and youths with major thalassemia. Jundishapur J Chronic Dis Care. 2014;3(4). doi: 10.17795/jjcdc-23366.

  • 2.

    Hatamloo Sadabadi M, Babapour Kheirodin J. [Comparison of quality of life and coping strategies in diabetic and non diabetic people]. J Shahid Sadoughi Univ Med Sci. 2012;20(5):581-92. Persian.

  • 3.

    Barani F, Kord Tamini B, Amiri Fard H. Comparing personality types, everyday memory, and rumination among stroke, heart attack, and dialysis patients. Jundishapur J Chronic Dis Care. 2017;7(1). doi: 10.5812/jjcdc.61331.

  • 4.

    Abolhasani F, Mohajerani-Tehrani MR, Tabatabaye-Molazi O, Larijani B. Burden of diabetes and its complications based on decades of research. Iran J Diabetes Lipid Disord. 2005;5(1):35-48.

  • 5.

    Larijani B, Zahedi F. [Epidemiology of diabetes mellitus in Iran]. Iran J Diabetes Lipid Disord. 2001;1(1):1-8. Persian.

  • 6.

    Rachman S. Emotional processing, with special reference to post-traumatic stress disorder. Int Rev Psychiatry. 2009;13(3):164-71. doi: 10.1080/09540260120074028.

  • 7.

    Lotfi S, Abolghasemi A, Narimani M. [A comparison of emotional processing and fear of positive/negative evaluations in women with social phobia and normal women]. Knowl Res Appli Psychol. 2013;14(3):101-11. Persian.

  • 8.

    Baker R, Thomas S, Thomas PW, Owens M. Development of an emotional processing scale. J Psychosom Res. 2007;62(2):167-78. doi: 10.1016/j.jpsychores.2006.09.005. [PubMed: 17270575].

  • 9.

    Mund M, Mitte K. The costs of repression: a meta-analysis on the relation between repressive coping and somatic diseases. Health Psychol. 2012;31(5):640-9. doi: 10.1037/a0026257. [PubMed: 22081940].

  • 10.

    Baker R, Thomas S, Thomas PW, Gower P, Santonastaso M, Whittlesea A. The Emotional Processing scale: scale refinement and abridgement (EPS-25). J Psychosom Res. 2010;68(1):83-8. doi: 10.1016/j.jpsychores.2009.07.007. [PubMed: 20004304].

  • 11.

    Raparia E, Coplan JD, Abdallah CG, Hof PR, Mao X, Mathew SJ, et al. Impact of childhood emotional abuse on neocortical neurometabolites and complex emotional processing in patients with generalized anxiety disorder. J Affect Disord. 2016;190:414-23. doi: 10.1016/j.jad.2015.09.019. [PubMed: 26551399].

  • 12.

    Yu GM, Li B. How subjective well-being affects emotional processing: The role of event-related potentials. Soc Behav Personal Int J. 2012;40(8):1285-92. doi: 10.2224/sbp.2012.40.8.1285.

  • 13.

    Taylor SE. Health psychology. 9th ed. Blacklick, Ohio: McGraw Hill; 2014.

  • 14.

    Sohrabi F. [Principles of spiritual intelligence]. J Ment Health. 2008;1(1):14-8. Persian.

  • 15.

    Moallemi S, Bakhshani NM, Raghibi M. [On the relationship between mental health, spiritual intelligence and dysfunctional attitudes in students of Systan and Baluchestan University, Southeast of Iran]. Quart J Fundamental Mental Health. 2011;3(48):702-9. Persian.

  • 16.

    Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol. 2011;3(2):57-71. doi: 10.1177/1758834010395342. [PubMed: 21789156]. [PubMed Central: PMC3126042].

  • 17.

    Panagiotopoulou N, van Delft FW, Hale JP, Stewart JA. Fertility preservation care for children and adolescents with cancer: An inquiry to quantify professionals' barriers. J Adolesc Young Adult Oncol. 2017;6(3):422-8. doi: 10.1089/jayao.2016.0087. [PubMed: 28186840].

  • 18.

    Hosseinian S, Ghasemzade S, Anoshe Z, Rasoli A. [Investigate relation of self-concept, quality of life and mental health in kindergarten' teachers Tehran]. Q J Career Organ. 2014;6(20):9-25. Persian.

  • 19.

    Bobes J, Gonzalez MP, Bascaran MT, Arango C, Saiz PA, Bousono M. Quality of life and disability in patients with obsessive-compulsive disorder. Eur Psychiatry. 2001;16(4):239-45. doi: 10.1016/s0924-9338(01)00571-5. [PubMed: 11418275].

  • 20.

    Snoek FJ. Quality of life: A closer look at measuring patients' well-being. Diabetes Spectrum. 2000;13(1):24-8.

  • 21.

    Nicholas PK, Corless IB, Webster A, McGibbon CA, Davis SM, Dolan SE, et al. A behavioral-medicine program in HIV. Implications for quality of life. J Holist Nurs. 2003;21(2):163-78. doi: 10.1177/0898010103021002006. [PubMed: 12794959].

  • 22.

    Clarke SA, Skinner R, Guest J, Darbyshire P, Cooper J, Shah F, et al. Health-related quality of life and financial impact of caring for a child with Thalassaemia Major in the UK. Child Care Health Dev. 2010;36(1):118-22. doi: 10.1111/j.1365-2214.2009.01043.x. [PubMed: 19961496].

  • 23.

    Torcharus K, Pankaew T. Health-related quality of life in Thai thalassemic children treated with iron chelation. Southeast Asian J Trop Med Public Health. 2011;42(4):951-9. [PubMed: 22299478].

  • 24.

    Mehrabizadeh Honarmand M, Eydi Baygi M, Davodi I. [Comparing the quality of life and mental health of patients with diabetes type I, II and non-diabetic individuals in Ahwaz, Iran]. J Res Behav Sci. 2013;10(7):654-62. Persian.

  • 25.

    Esteban y Pena MM, Hernandez Barrera V, Fernandez Cordero X, Gil de Miguel A, Rodriguez Perez M, Lopez-de Andres A, et al. Self-perception of health status, mental health and quality of life among adults with diabetes residing in a metropolitan area. Diabetes Metab. 2010;36(4):305-11. doi: 10.1016/j.diabet.2010.02.003. [PubMed: 20483647].

  • 26.

    Camacho F, Anderson RT, Bell RA, Goff DJ, Duren-Winfield V, Doss DD, et al. Investigating correlates of health related quality of life in a low-income sample of patients with diabetes. Qual Life Res. 2002;11(8):783-96. doi: 10.1023/a:1020858102483. [PubMed: 12482162].

  • 27.

    Thommasen HV, Berkowitz J, Thommasen AT, Michalos AC. Understanding relationships between diabetes mellitus and health-related quality of life in a rural community. Rural Remote Health. 2005;5(3):441. [PubMed: 16120021].

  • 28.

    Lloyd CE, Orchard TJ. Physical and psychological well-being in adults with Type 1 diabetes. Diabetes Res Clin Pract. 1999;44(1):9-19. doi: 10.1016/s0168-8227(99)00004-2. [PubMed: 10414935].

  • 29.

    Por mohseni F, Shirzad G. [The comparison of self-disclosure, intimacy and emotional processing in female with and without social phobia]. Couns Cult Psychother. 2015;6(24):145-63. Persian.

  • 30.

    Frisch MB, Cornell J, Villanueva M, Retzlaff PJ. Clinical validation of the quality of life inventory. A measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess. 1992;4(1):92-101. doi: 10.1037/1040-3590.4.1.92.

  • 31.

    Kazemi Rezaei SA, Moradi A, Hasani J. A comparative study on emotional regulation, selfcontrol, and defense mechanisms in patients with cardiovascular diseases or diabetes, and Healthy people. Iran J Psychiatr Nurs. 2018;6(1):42-5.

  • 32.

    Glasemann M, Kanstrup AM. Emotions on diabetes: A design case of user mock-ups by young people living with diabetes. CoDesign. 2011;7(2):123-30. doi: 10.1080/15710882.2011.609894.

  • 33.

    Weinberger DA, Schwartz GE. Distress and restraint as superordinate dimensions of self-reported adjustment: A typological perspective. J Pers. 1990;58(2):381-417. doi: 10.1111/j.1467-6494.1990.tb00235.x. [PubMed: 2213473].

  • 34.

    Newton TL, Contrada RJ. Repressive coping and verbal-autonomic response dissociation: The influence of social context. J Pers Soc Psychol. 1992;62(1):159-67. doi: 10.1037//0022-3514.62.1.159. [PubMed: 1538313].

  • 35.

    Weinberger DA, Schwartz GE, Davidson RJ. Low-anxious, high-anxious, and repressive coping styles: Psychometric patterns and behavioral and physiological responses to stress. J Abnorm Psychol. 1979;88(4):369-80. doi: 10.1037//0021-843x.88.4.369. [PubMed: 479459].

  • 36.

    Pandey R, Choubey AK. Emotion and health: An overview. SIS J Projective Psychol Ment Health. 2010;17(2).

  • 37.

    Aldao A, Nolen-Hoeksema S, Schweizer S. Emotion-regulation strategies across psychopathology: A meta-analytic review. Clin Psychol Rev. 2010;30(2):217-37. doi: 10.1016/j.cpr.2009.11.004. [PubMed: 20015584].

  • 38.

    Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia. 2006;49(3):469-77. doi: 10.1007/s00125-005-0094-2. [PubMed: 16432706].

  • 39.

    Crakowski MS. Health-related quality of life outcomes in clinical research. Am J Epidemiol. 1999:283.

  • 40.

    Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clin Diabetes. 2004;22(3):123-7. doi: 10.2337/diaclin.22.3.123.

  • 41.

    Bradley C, Gamsu DS. Guidelines for encouraging psychological well-being: report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med. 1994;11(5):510-6. doi: 10.1111/j.1464-5491.1994.tb00316.x. [PubMed: 8088133].

  • 42.

    Moser DK. Psychosocial factors and their association with clinical outcomes in patients with heart failure: Why clinicians do not seem to care. Eur J Cardiovasc Nurs. 2016;1(3):183-8. doi: 10.1016/s1474-5151(02)00033-6.

  • 43.

    Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997;20(4):562-7. doi: 10.2337/diacare.20.4.562. [PubMed: 9096981].

  • COMMENTS

    LEAVE A COMMENT HERE: